SCHEMBL4908889

SCHEMBL4908889

CCN(c1ccc(OCC(F)(F)C(F)F)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ESR1 P03372 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KDM4E B2RXH2 1/20 0.42
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 2/20 0.41
KMT2A Q03164 2/20 0.41
HCRTR2 O43614 1/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902441 0.91 NPSR1 (0.43) LMNAESR1ALDH1A1KDM4EMAPT
SCHEMBL4909058 0.90 LMNA (0.50) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4894383 0.90 LMNA (0.44) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4905605 0.83 LMNA (0.42) LMNAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL4905352 0.82 NPSR1 (0.41) LMNAESR1ALDH1A1KDM4EMAPT
SCHEMBL4906642 0.81 HCRTR2 (0.54) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4907142 0.81 HCRTR2 (0.54) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4894659 0.81 LMNA (0.53) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4905308 0.81 MMP2 (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905993 0.80 LMNA (0.56) LMNAESR1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ESR1 585/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ESR1 585/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.